Literature DB >> 21901288

Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.

Yinan Hua1, Yingmei Zhang, Asli F Ceylan-Isik, Loren E Wold, Jennifer M Nunn, Jun Ren.   

Abstract

Aging is often accompanied with geometric and functional changes in the heart, although the underlying mechanisms remain unclear. Recent evidence has described a potential role of Akt and autophagy in aging-associated organ deterioration. This study was to examine the impact of cardiac-specific Akt activation on aging-induced cardiac geometric and functional changes and underlying mechanisms involved. Cardiac geometry, contractile and intracellular Ca(2+) properties were evaluated using echocardiography, edge-detection and fura-2 techniques. Level of insulin signaling and autophagy was evaluated by western blot. Our results revealed cardiac hypertrophy (enlarged chamber size, wall thickness, myocyte cross-sectional area), fibrosis, decreased cardiac contractility, prolonged relengthening along with compromised intracellular Ca(2+) release and clearance in aged (24-26 month-old) mice compared with young (3-4 month-old) mice, the effects of which were accentuated by chronic Akt activation. Aging enhanced Akt and mTOR phosphorylation while reducing that of PTEN, AMPK and ACC with a more pronounced response in Akt transgenic mice. GSK3β phosphorylation and eNOS levels were unaffected by aging or Akt overexpression. Levels of beclin-1, Atg5 and LC3-II-to-LC3-I ratio were decreased in aged hearts, the effect of which with the exception of Atg 5 was exacerbated by Akt overactivation. Levels of p62 were significantly enhanced in aged mice with a more pronounced increase in Akt mice. Neither aging nor Akt altered β-glucuronidase activity and cathepsin B although aging reduced LAMP1 level. In addition, rapamycin reduced aging-induced cardiomyocyte contractile and intracellular Ca(2+) dysfunction while Akt activation suppressed autophagy in young but not aged cardiomyocytes. In conclusion, our data suggest that Akt may accentuate aging-induced cardiac geometric and contractile defects through a loss of autophagic regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901288     DOI: 10.1007/s00395-011-0222-8

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  83 in total

1.  Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway.

Authors:  Nirmal Parajuli; Yuan Yuan; Xiaoxu Zheng; Djahida Bedja; Zheqing P Cai
Journal:  Basic Res Cardiol       Date:  2012-02-02       Impact factor: 17.165

2.  Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging.

Authors:  Stela Florea; Ahmad Anjak; Wen-Feng Cai; Jiang Qian; Elizabeth Vafiadaki; Sarah Figueria; Kobra Haghighi; Jack Rubinstein; John Lorenz; Evangelia G Kranias
Journal:  Basic Res Cardiol       Date:  2012-07-10       Impact factor: 17.165

3.  Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Authors:  Asli F Ceylan-Isik; Maolong Dong; Yingmei Zhang; Feng Dong; Subat Turdi; Sreejayan Nair; Masashi Yanagisawa; Jun Ren
Journal:  Basic Res Cardiol       Date:  2013-02-05       Impact factor: 17.165

Review 4.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  Role of autophagy in metabolic syndrome-associated heart disease.

Authors:  Sidney Y Ren; Xihui Xu
Journal:  Biochim Biophys Acta       Date:  2014-05-05

Review 6.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Mahesh P Gupta
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

Review 7.  Rapalogs and mTOR inhibitors as anti-aging therapeutics.

Authors:  Dudley W Lamming; Lan Ye; David M Sabatini; Joseph A Baur
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 8.  Metabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics.

Authors:  Jun Ren; James R Sowers; Yingmei Zhang
Journal:  Trends Endocrinol Metab       Date:  2018-08-22       Impact factor: 12.015

Review 9.  Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases.

Authors:  Jun Ren; Yingmei Zhang
Journal:  Trends Pharmacol Sci       Date:  2018-10-26       Impact factor: 14.819

10.  2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.

Authors:  Ai Fujita; Fumi Takahashi-Yanaga; Sachio Morimoto; Tatsuya Yoshihara; Masaki Arioka; Kazunobu Igawa; Katsuhiko Tomooka; Sumio Hoka; Toshiyuki Sasaguri
Journal:  Hypertens Res       Date:  2016-09-15       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.